Back to TCRX

JPMORGAN CHASE & CO → TCRX

JPMORGAN CHASE & CO TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$48
Q3 2026
Peak value
$399K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$6K
Q3 2025$399K
Q3 2025$27K
Q4 2025$4K
Q4 2025$15K
Q4 2025$15K
Q1 2026$1K
Q1 2026$244
Q1 2026$14K
Q2 2026$1K
Q2 2026$275
Q2 2026$15K
Q3 2026$374
Q3 2026$123
Q3 2026$48

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$48150——
Q3 2026$123388——
Q3 2026$3741.2K——
Q2 2026$15K15.0K——
Q2 2026$275281——
Q2 2026$1K1.2K——
Q1 2026$14K15.0K——
Q1 2026$244259——
Q1 2026$1K1.2K——
Q4 2025$15K15.0K——
Q4 2025$15K14.5K——
Q4 2025$4K3.8K——
Q3 2025$27K15.0K——
Q3 2025$399K219.3K——
Q3 2025$6K3.4K——

Other funds holding TCRX

Other JPMORGAN CHASE & CO positions

NVDA

NVIDIA CORPORATION

$62.5B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.2B
NVDA

NVIDIA CORPORATION

$53.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$49.4B